51.91
2.81%
+1.42
Pre-mercato:
52.00
0.09
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
100.00%
-
|
0.346 | 0.988 | 2.679 | 0.709 |
Operating Expenses
|
5.62%
62.66
|
59.32 | 53.98 | 50.66 | 48.27 |
Benefits Costs and Expenses |
218.54
|
- | - | - | 168.66 |
Costs And Expenses |
8.00%
54.58
|
59.32 | 53.98 | 50.66 | 44.30 |
Depreciation and Amortization |
4.03%
0.262
|
0.273 | 0.28 | 0.283 | 0.28 |
Operating Income/Loss |
6.24%
-62.66
|
-58.98 | -52.99 | -47.98 | -47.56 |
Nonoperating Income/Loss |
168.76%
6.762
|
2.516 | 2.016 | 1.983 | 2.565 |
Income/Loss From Continuing Operations Before Tax |
63,262%
-218.54
|
0.346 | 0.988 | 2.679 | -167.95 |
Income/Loss From Continuing Operations After Tax |
4.59%
-60.10
|
-57.46 | -50.98 | -45.99 | -44.99 |
Net Income/Loss
|
4.59%
-60.10
|
-57.46 | -50.98 | -45.99 | -44.99 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
94.60%
3.068
|
56.81 | 54.27 | 53.91 | 0.626 |
Diluted Average Shares |
94.60%
3.068
|
56.81 | 54.27 | 53.91 | 0.626 |
Basic Earnings Per Share |
12.87%
-0.88
|
-1.01 | -0.94 | -0.85 | -0.83 |
Diluted Earnings Per Share |
12.87%
-0.88
|
-1.01 | -0.94 | -0.85 | -0.83 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):